Fuan Pharmaceutical (300194.SZ): Methyl bromide injection solution hydrochloride has obtained a drug registration certificate.

Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianheng Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration for the drug: "Bromhexine Hydrochloride Injection". Bromhexine Hydrochloride Injection is used for patients with chronic bronchitis and other respiratory diseases such as asthma, bronchiectasis, and silicosis who have difficulty taking oral medication and have phlegm that is difficult to cough up. According to the data query platform of the National Medical Products Administration, as of now, a total of 30 companies (including Tianheng Pharmaceutical) have passed consistency evaluation or been considered as passing consistency evaluation for this drug.